Modification of release rates of cyclosporin A from polyl(L-lactic acid) microspheres by fatty acid esters and in-vivo evaluation of the microspheres

Journal of Controlled Release

Volumn 58, Issue 2, 1999, Pages 133-141

  Urata, T ^a   Arimori, K ^a   Nakano, M ^a  

^a KUMAMOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Adjuvant; Cyclosporin A; Fatty acid esters; Microspheres; Poly(L lactic acid); Poly(lactide co glycolide)

Indexed keywords

CYCLOSPORIN A; FATTY ACID ESTER; MICROSPHERE; POLYGLACTIN;

ADJUVANT ARTHRITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHEMICAL MODIFICATION; CONTROLLED RELEASE FORMULATION; DRUG RELEASE; ENCAPSULATION; MALE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0032990165     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(98)00146-1     Document Type: Article

References (19)

1. Richardson C., Emery P. Clinical use of cyclosporin in rheumatoid arthritis. Drugs. 50(Suppl 1):1995;26-36.
2. Sajjadi H., Soheilian M., Ahmadieh H., Hassanein K., Parvin M., Azarmina M., Ehyaee V., Amiransari B. Low dose cyclosporin-A therapy in Behcet's disease. J. Ocul. Pharmacol. 10:1994;553-560.
3. Mehta M., Venkataramanan R., Buckart G.J. Effects of bile on cyclosporin absorption in liver transplant patients. Br. J. Clin. Pharmacol. 25:1984;579-584.
4. Yee G.C., McGuire T.R. Pharmacokinetic drug interactions with cyclosporin (Part I). Clin. Pharmacokinet. 19:1990;319-332.
5. Campana C., Regazzi M.B., Buggia I., Molinaro M. Clinically significant drug interactions with cyclosporin. An update. Clin. Pharmacokinet. 30:1996;141-179.
6. Okada H., Toguchi H. Biodegradable microspheres in drug delivery. Crit. Rev. Ther. Drug Carrier Syst. 12:1995;1-99.
7. Okada H., Doken Y., Ogawa Y., Toguchi H. Preparation of three-month depot injectable microspheres of leuprorelin acetate using biodegradable polymers. Pharm. Res. 11:1994;1143-1147.
8. Sanchez A., Vila-Jato J.L., Alonso M.J. Development of biodegradable microspheres and nanospheres for the controlled release of cyclosporin A. Int. J. Pharmaceut. 99:1993;263-273.
9. Juni K., Ogata J., Nakano M., Ichihara T., Mori K., Akagi M. Preparation and evaluation in vitro and in vivo of polylactic acid microspheres containing doxorubicin. Chem. Pharm. Bull. 33:1985;313-318.
10. Juni K., Ogata J., Matsui N., Kubota M., Nakano M. Control of release rate of bleomycin from polylactic acid microspheres by additives. Chem. Pharm. Bull. 33:1985;1609-1614.
11. Juni K., Ogata J., Matsui N., Kubota M., Nakano M. Modification of release rate of aclarubicin from polylactic acid microspheres by using additives. Chem. Pharm. Bull. 33:1985;1734-1738.
12. Wakiyama N., Juni K., Nakano M. Influence of physicochemical properties of polylactic acid on the characteristics and in vitro release patterns of polylactic acid microspheres containing local anesthetics. Chem. Pharm. Bull. 30:1982;2621-2628.
13. Wakiyama N., Juni K., Nakano M. Preparation and evaluation in vitro and in vivo of polylactic acid microspheres containing dibucaine. Chem. Pharm. Bull. 30:1982;3719-3727.
14. Takahashi H., Urata T., Nakano M. Preparation and evaluation of polylactate microspheres containing cisplatin. Drug Delivery System. 8:1993;251-256.
15. Wakiyama N., Juni K., Nakano M. Preparation and evaporation in vitro of polylactic acid microspheres containing local anesthetics. Chem. Pharm. Bull. 29:1981;3363-3368.
16. Kubo M., Asano T., Shiomoto H., Matsuda H. Studies on rehmanniae radix. I. Effect of 50% ethanolic extract from steamed and dried rehmanniae radix on hemorheology in arthritic and thrombosic rats. Biol. Pharm. Bull. 17:1994;1282-1286.
17. Koga T., Pearson C.M. Immunogenicity and arthritogenicity in the rat of an antigen from Mycobacterium tuberculosis wax D. J. Immunol. 111:1973;599-608.
18. Takeshima K., Sunagawa N., Nagata S., Hirano K., Takagishi Y. Effect of morphological properties on drug release from biodegradable microspheres. Yakugaku Zasshi. 112:1992;203-210.
19. Kubota M., Nakano M., Juni K. Mechanism of enhancement of the release rate of aclarubicin from poly-β-hydroxybutyric acid microspheres by fatty acid esters. Chem. Pharm. Bull. 36:1988;333-337.